Medicure Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,602.70
8,949.50
22,083.10
29,304.80
27,132.80
29,109.40
Cost of Goods Sold (COGS) incl. D&A
676.50
1,185.10
2,263.70
3,807.70
3,464.70
4,152.20
Gross Income
1,926.20
7,764.30
19,819.50
25,497.10
23,668.10
24,957.10
SG&A Expense
3,950.60
6,660.50
15,051.40
18,612.60
20,015.90
26,183.40
EBIT
2,024.40
1,103.80
4,768.10
-
3,652.30
1,226.20
Unusual Expense
110.50
723.70
3,042.60
347.40
553.20
1,473
Non Operating Income/Expense
21.50
2,086.00
68.80
2,533.90
572.10
6,105.50
Interest Expense
418.10
433.60
367.30
208.60
89.90
24
Pretax Income
2,574.30
2,032.50
1,289.40
3,794.50
2,437.00
4,822.50
Income Tax
-
-
379.00
170.20
9,059.60
896.90
Consolidated Net Income
2,574.30
2,032.50
1,668.40
3,624.30
11,496.70
3,925.60
Net Income
2,574.30
2,032.50
1,668.40
3,624.30
11,496.70
3,925.60
Net Income After Extraordinaries
2,574.30
2,032.50
1,668.40
19,734.00
20,427.50
3,925.60
Net Income Available to Common
2,574.30
2,032.50
1,668.40
26,982.60
11,833.40
3,925.60
EPS (Basic)
0.21
0.17
0.12
1.80
2.78
0.25
Basic Shares Outstanding
12,196.50
12,204.80
13,461.60
15,002.00
15,636.90
15,791.40
EPS (Diluted)
0.21
0.15
0.11
1.56
2.78
0.24
Diluted Shares Outstanding
12,196.50
13,843.10
15,765.60
17,316.40
15,636.90
16,563.70
EBITDA
1,487.40
1,840.20
5,459.00
8,318.00
3,750.10
927
Non-Operating Interest Income
0.20
0.10
-
-
-
1,440.20

About Medicure

View Profile
Address
1250 Waverley Street
Winnipeg Manitoba R3T 6C6
Canada
Employees -
Website http://www.medicure.com
Updated 07/08/2019
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of human therapeutics. It focuses on the marketing and distribution ofits acute care cardiovascular drug, AGGRASTAT. The company was founded by Albert D.